After decades of hope and hype, this year saw the coming of age of the “magic
bullet” approach to cancer. Glivec, the first “small molecule” cancer therapy,
got the fastest US approval of any cancer drug in history for treating a rare
leukaemia. It proved successful against a stomach cancer, too, and to complete a
busy year it has been granted a British licence. Glivec alone won’t be a miracle
cure for cancer. But with at least six other Glivec-like drugs in trials, each
aimed at a different kind of cancer, it won’t be long before doctors can tailor
treatments to each patient.
More from New Scientist
Explore the latest news, articles and features
Space
Hubble Space Telescope is falling to Earth – should NASA save it?
News
Space
A robot called GIMLI will explore a lunar cave for a future moon base
91ɫÇéƬ
91ɫÇéƬ
The economic benefits of the covid vaccines may be double what we thought
News
Humans
Tomb in Siberia reveals humans were using cannabis 2800 years ago
News
Popular articles
Trending New Scientist articles